Table 1.
Demographic Information for the 40 Solid Organ or Allogenic Stem Cell Transplant Patients Included in the Study
| Patient | Age, y/Sex | Days Since Dose 1, 2 | Vaccine | Transplant Type | Years Since Transplant | Current Immunosuppressant Medications |
|---|---|---|---|---|---|---|
| 1 | 67/M | 67, 40 | P | Heart | 2.1 | Everolimus, tacrolimus |
| 2 | 69/F | 79, 58 | P | Heart | 8.0 | Mycophenolate, tacrolimus |
| 3 | 69/M | 71, 42 | P | Heart | 4.4 | Everolimus, mycophenolate, tacrolimus |
| 4 | 50/F | 48, 20 | M | Heart | 12.7 | Mycophenolate, tacrolimus |
| 5 | 61/M | 67, 41 | M | Heart | 2.8 | Mycophenolate, tacrolimus |
| 6 | 28/F | 50, 29 | P | Heart and lung | 4.8 | Mycophenolate, prednisone, tacrolimus |
| 7 | 78/F | 56, 28 | M | Kidney | 9.0 | Azothioprine, prednisone, tacrolimus |
| 8 | 68/M | 68, 47 | P | Kidney | 2.9 | Mycophenolate, prednisone, tacrolimus |
| 9 | 71/M | 64, 25 | P | Kidney | 4.3 | Mycophenolate, prednisone, tacrolimus |
| 10 | 45/F | 76, 23 | P | Kidney | 0.7 | Mycophenolate, prednisone, tacrolimus |
| 11 | 71/M | 77, 55 | P | Kidney | 6.0 | Mycophenolate, prednisone, tacrolimus |
| 12 | 87/M | 93, 72 | P | Kidney | 7.1 | Mycophenolate, tacrolimus |
| 13 | 57/M | 14, NA | J | Kidney | 3.6 | Mycophenolate, prednisone, tacrolimus |
| 14 | 68/M | 76, 48 | M | Kidney | 7.7 | Mycophenolate, prednisone, tacrolimus |
| 15 | 67/M | 74, 53 | P | Kidney | 18.0 | Mycophenolate, prednisone, tacrolimus |
| 16 | 72/F | 72, 47 | P | Kidney | 0.8 | Mycophenolate, prednisone, tacrolimus |
| 17 | 70/F | 73, 45 | P | Kidney | 3.6 | Mycophenolate, prednisone, tacrolimus |
| 18 | 78/F | 93, 65 | M | Kidney | 8.4 | Prednisone, tacrolimus |
| 19 | 74/M | 100, 72 | M | Kidney | 0.9 | Mycophenolate, prednisone, tacrolimus |
| 20 | 68/M | 85, 63 | P | Kidney | 4.2 | Mycophenolate, tacrolimus |
| 21 | 63/M | 61, 40 | P | Kidney | 11.6 | Mycophenolate, prednisone, tacrolimus |
| 22 | 81/M | 93, 65 | M | Liver | 22.8 | Tacrolimus |
| 23 | 69/F | 66, 38 | M | Liver | 8.1 | Sirolimus, tacrolimus |
| 24 | 73/M | 97, 65 | M | Liver | 7.4 | Mycophenolate, prednisone, tacrolimus |
| 25 | 66/M | 73, 52 | P | Liver | 3.1 | Mycophenolate, tacrolimus |
| 26 | 66/F | 71, 30 | P | Liver | 8.4 | Mycophenolate, tacrolimus |
| 27 | 67/M | 73, 44 | M | Liver | 2.2 | Mycophenolate, tacrolimus |
| 28 | 60/M | 44, NA | J | Liver | 4.9 | Mycophenolate, tacrolimus |
| 29 | 74/F | 62, 35 | P | Liver | 19.4 | Prednisone, tacrolimus |
| 30 | 71/M | 67, 25 | P | Lung | 5.7 | Mycophenolate, prednisone, tacrolimus |
| 31 | 73/F | 82, 61 | P | Lung | 12.6 | Everolimus, mycophenolate, prednisone, tacrolimus |
| 32 | 56/F | 37, 16 | P | Lung | 13.8 | Mycophenolate, prednisone, tacrolimus |
| 33 | 58/M | 71, 47 | P | Lung | 8.7 | Prednisone, sirolimus, tacrolimus |
| 34 | 55/M | 44, 23 | P | Lung | 8.1 | Mycophenolate, prednisone, tacrolimus |
| 35 | 75/M | 93, 65 | M | Lung | 6.1 | Mycophenolate, prednisone, tacrolimus |
| 36 | 74/M | 69, 30 | P | Lung, bilateral | 6.1 | Everolimus, prednisone, tacrolimus |
| 37 | 73/M | 89, 60 | M | Lung, bilateral | 3.5 | Mycophenolate, prednisone, tacrolimus |
| 38 | 69/M | 78, 50 | P | Lung, bilateral | 3.7 | Everolimus, mycophenolate, prednisone, tacrolimus |
| 39 | 72/M | 82, 60 | P | Stem cell, allogeneic | 2.8 | Prednisone, tacrolimus |
| 40 | 69/M | 85, 56 | M | Stem cell, allogeneic | 0.5 | Tacrolimus |
J, Janssen vaccine; M, Moderna vaccine; NA, not applicable; P, Pfizer vaccine.